The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state hea...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-10-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9032/3/4/948 |
id |
doaj-6a2aabd68aa64f1eab9e63cc0c981012 |
---|---|
record_format |
Article |
spelling |
doaj-6a2aabd68aa64f1eab9e63cc0c9810122020-11-24T23:06:00ZengMDPI AGHealthcare2227-90322015-10-013494896310.3390/healthcare3040948healthcare3040948The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014Katrina F. Trivers0Juan L. Rodriguez1Summer L. Cox2Barbara E. Crane3Debra Duquette4Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USADivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USAOregon Health Authority, Portland, OR 97232, USAGeorgia Department of Public Health, Atlanta, GA 30303-3142, USAMichigan Department of Health and Human Services, Lansing, MI 48909, USAIn 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state health departments to promote the application of best practices for evidence-based breast cancer genomics through education, surveillance, and policy activities. The FOA required that applicants focus on activities related to hereditary breast and ovarian cancer (HBOC). The DCPC funded three states: Georgia, Michigan, and Oregon. Georgia was a first-time recipient of cancer genomics funding, whereas Michigan and Oregon had long standing activities in cancer genomics and had received CDC funding in the past. By the end of the funding period, each state had well-functioning and impactful state-based programs in breast cancer genomics. This article highlights the impact of a few key state activities by using CDC’s Science Impact Framework. There were challenges to implementing public health genomics programs, including the need to develop relevant partnerships, the highly technical nature of the subject matter, a lack of genetic services in certain areas, and the difficulty in funding genetic services. Georgia, Michigan, and Oregon have served as models for others interested in initiating or expanding cancer genomics programs, and they helped to determine what works well for promoting and integrating public health genomics into existing systems.http://www.mdpi.com/2227-9032/3/4/948genomicsgenetic servicesimplementationstate health departmentsBRCAbreast cancerovarian cancerhereditary breastovarian cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katrina F. Trivers Juan L. Rodriguez Summer L. Cox Barbara E. Crane Debra Duquette |
spellingShingle |
Katrina F. Trivers Juan L. Rodriguez Summer L. Cox Barbara E. Crane Debra Duquette The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014 Healthcare genomics genetic services implementation state health departments BRCA breast cancer ovarian cancer hereditary breast ovarian cancer |
author_facet |
Katrina F. Trivers Juan L. Rodriguez Summer L. Cox Barbara E. Crane Debra Duquette |
author_sort |
Katrina F. Trivers |
title |
The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014 |
title_short |
The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014 |
title_full |
The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014 |
title_fullStr |
The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014 |
title_full_unstemmed |
The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014 |
title_sort |
activities and impact of state programs to address hereditary breast and ovarian cancer, 2011–2014 |
publisher |
MDPI AG |
series |
Healthcare |
issn |
2227-9032 |
publishDate |
2015-10-01 |
description |
In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state health departments to promote the application of best practices for evidence-based breast cancer genomics through education, surveillance, and policy activities. The FOA required that applicants focus on activities related to hereditary breast and ovarian cancer (HBOC). The DCPC funded three states: Georgia, Michigan, and Oregon. Georgia was a first-time recipient of cancer genomics funding, whereas Michigan and Oregon had long standing activities in cancer genomics and had received CDC funding in the past. By the end of the funding period, each state had well-functioning and impactful state-based programs in breast cancer genomics. This article highlights the impact of a few key state activities by using CDC’s Science Impact Framework. There were challenges to implementing public health genomics programs, including the need to develop relevant partnerships, the highly technical nature of the subject matter, a lack of genetic services in certain areas, and the difficulty in funding genetic services. Georgia, Michigan, and Oregon have served as models for others interested in initiating or expanding cancer genomics programs, and they helped to determine what works well for promoting and integrating public health genomics into existing systems. |
topic |
genomics genetic services implementation state health departments BRCA breast cancer ovarian cancer hereditary breast ovarian cancer |
url |
http://www.mdpi.com/2227-9032/3/4/948 |
work_keys_str_mv |
AT katrinaftrivers theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT juanlrodriguez theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT summerlcox theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT barbaraecrane theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT debraduquette theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT katrinaftrivers activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT juanlrodriguez activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT summerlcox activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT barbaraecrane activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 AT debraduquette activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014 |
_version_ |
1725624387273490432 |